testosterone undecanoate

Small molecule

Approvedregulatory verdict

Evidence outlook

Approved: Hypogonadism

Regulatory approval supersedes design-level evidence grading; the trials behind approval are preserved below as the drug's evidence history.

Also approved (1)
CA
  • Testosterone replacement therapy in adult males with male hypogonadism (TLANDO capsules)
Product first approved 2026finviz.com

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase. Studies where this drug served as another program's comparator, or is merely referenced, are listed separately below.

Phase 3 (18)
Hypogonadism
NCT03198728 · Marius Pharmaceuticals
2017-07-05 – 2020-05-01 · Hypogonadism, Male
What this study did
NCT04467697 · Marius Pharmaceuticals
2018-09-18 – 2020-05-01 · Hypogonadism, Male
What this study did
NCT03868059 · Lipocine Inc.
2018-04-30 – 2019-02-21 · Hypogonadism, Male
What this study did
NCT03242408 · Lipocine Inc.
2017-01 – 2017-07 · Hypogonadism, Male
What this study did
NCT02722278 · Clarus Therapeutics, Inc.
2016-03 – 2016-11 · Hypogonadism
What this study did
NCT02514629 · Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
2013-07-04 – 2016-07-12 · Hypogonadism, Obesity
What this study did
NCT02081300 · Lipocine Inc.
2014-02 – 2015-05 · Male Hypogonadism
What this study did
NCT01699178 · Clarus Therapeutics, Inc.
2012-08 – 2014-04 · Male Hypogonadism
What this study did
NCT01403116 · Clarus Therapeutics, Inc.
2011-07 – 2013-09 · Male Hypogonadism
What this study did
NCT01765179 · Clarus Therapeutics, Inc.
2013-01 – 2013-07 · Male Hypogonadism
What this study did
NCT00696748 · Russian Academy of Medical Sciences
2005-10 – 2010-12 · Metabolic Syndrome, Hypogonadism
What this study did
NCT04545450 · Unita Complessa di Ostetricia e Ginecologia
2008-11-04 – 2010-10-15 · Transgenderism, Hypogonadism
What this study did
NCT00467870 · Endo USA Inc., a Keenova Therapeutics Company
2006-03 – 2009-07 · Hypogonadism, Primary Hypogonadism, Secondary Hypogonadism
What this study did
NCT00220298 · Bayer
2003-02 – 2007-10 · Hypogonadism
What this study did
Other / comorbidity
NCT00230984 · University Hospital, Grenoble
2003-04 – 2008-06 · Chronic Respiratory Failure, Nutritional Depletion
What this study did
NCT00146146 · Unita Complessa di Ostetricia e Ginecologia
2005-05 – 2008-01 · Transsexualism
What this study did
NCT00117000 · University of Adelaide
2003-07 – 2007-02 · Malnutrition, Aging
What this study did
Phase 2/3 (2)
Hypogonadism
NCT01206270 · University of Roma La Sapienza
2009-06 – 2018-06 · Klinefelter Syndrome, Hypergonadotropic Hypogonadism, Hypergonadotropic Azospermia, Hypergonadotropic Cryptozoospermia
What this study did
Other / comorbidity
NCT05964920 · Norwegian School of Sport Sciences
2024-09-01 – 2026-02-06 · Healthy Aging, Age-Related Sarcopenia, Testosterone Deficiency
What this study did
Phase 2 (19)
Hypogonadism
NCT04798469 · Brigham and Women's Hospital
2022-01-10 – 2027-12-30 · Opioid Use, Pain, Hypogonadism, Male
What this study did
NCT04049331 · Seattle Institute for Biomedical and Clinical Research
2021-03-22 – 2027-01-30 · Hypogonadism, Male, Fatigue Syndrome, Chronic
What this study did
NCT01919294 · Sheffield Teaching Hospitals NHS Foundation Trust
2013-07 – 2017-01-30 · Nonalcoholic Steatohepatitis, Hypogonadism
What this study did
NCT02921386 · Clarus Therapeutics, Inc.
2016-10 – 2017-01-21 · Hypogonadism
What this study did
NCT00924612 · Clarus Therapeutics, Inc.
2009-07 – 2010-07 · Male Hypogonadism
What this study did
NCT00911586 · Clarus Therapeutics, Inc.
2009-07 – 2010-01 · Male Hypogonadism, Primary Hypogonadism, Secondary Hypogonadism
What this study did
NCT00695110 · Clarus Therapeutics, Inc.
2008-06 – 2009-08 · Hypogonadism
What this study did
NCT02697188 · Clarus Therapeutics, Inc.
2007-11 – 2008-04 · Hypogonadism
What this study did
NCT00452322 · University Hospital Muenster
1997-04 – 2007-01 · Hypogonadism
What this study did
NCT00434824 · Merck Sharp & Dohme LLC
2001-11 – 2004-07 · Hypogonadism, Androgens
What this study did
Other / comorbidity
NCT07512323 · Rune Skovgaard Rasmussen
2026-08-01 – 2030-09-30 · Frail Elderly Patients, Hypogonadal Males, Testosterone Replacement Therapy, Falls (Accidents) in Old Age
What this study did
NCT03910738 · University Hospital, Strasbourg, France
2019-10-29 – 2027-12 · Multiple Sclerosis, Relapsing-Remitting
What this study did
NCT05081193 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2022-03-07 – 2026-12-04 · Prostate Cancer, Castration-resistant Prostate Cancer, Metastatic Castration-resistant Prostate Cancer
What this study did
NCT06082817 · San Diego Sexual Medicine
2025-01-01 – 2025-12-31 · Hypoactive Sexual Desire Disorder
What this study did
NCT03576001 · Brigham and Women's Hospital
2019-08-23 – 2025-03-30 · Spinal Cord Injuries
What this study did
NCT01516554 · Health Sciences Centre, Winnipeg, Manitoba
2012-02 – 2014-07 · Multiple Sclerosis, Fatigue
What this study did
NCT01724658 · Chulalongkorn University
2012-06 – 2013-05 · Female Sexual Dysfunction
What this study did
NCT00403793 · Organon and Co
2003-10 – 2006-12 · Contraception
What this study did
NCT00239590 · Imperial College London
2001-06 – 2004-04-24 · Coronary Heart Disease
What this study did
Phase 1/2 (3)
Hypogonadism
NCT06312761 · University of Washington
2024-06-01 – 2025-12-31 · Hypogonadism, Male
What this study did
NCT03335254 · TesoRx Pharma, LLC
2017-11-06 – 2018-05-03 · Hypogonadism, Hypogonadism, Male, Gonadal Disorders, Endocrine System Diseases, Testosterone Deficiency
What this study did
NCT02670343 · Clarus Therapeutics, Inc.
2016-01 – 2016-03 · Hypogonadism
What this study did
Phase 1 (2)
Hypogonadism
NCT03973840 · Clarus Therapeutics, Inc.
2018-07-15 – 2018-07-31 · Hypogonadism, Male
What this study did
Other / comorbidity
NCT01346319 · Abbott
2011-04 – 2011-09 · Hypogonadal Males
What this study did
Phase 4 (9)
Hypogonadism
NCT03851627 · Alexandra Kautzky-Willer
2022-01-25 – 2028-12 · Fatty Liver, Overweight/Obesity, Prediabetes/Type2 Diabetes Mellitus, Hypogonadism, Male
What this study did
NCT03721497 · Esbjerg Hospital - University Hospital of Southern Denmark
2020-12-17 – 2025-11-11 · Bariatric Surgery Candidate, Male Hypogonadism, Muscle Loss
What this study did
NCT03792321 · University Medical Centre Ljubljana
2014-01-10 – 2018-03-05 · Hypogonadism, Male, Diabetes Mellitus, Type 2, Obesity
What this study did
NCT03126656 · University of Roma La Sapienza
2016-09 – 2017-04 · Hypogonadism, Chronic Heart Failure
What this study did
NCT00421460 · Chulalongkorn University
2007-01 – 2011-05 · Hypogonadism, Erectile Dysfunction
What this study did
Other / comorbidity
NCT04983940 · University of Miami
2021-06-18 – 2023-04-06 · Testosterone Deficiency
What this study did
NCT04120363 · Pennington Biomedical Research Center
2019-09-23 – 2021-07-08 · Caloric Restriction, Exercise, Sleep
What this study did
NCT01813201 · Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
2011-03 – 2014-03 · Heart Failure
What this study did
NCT00555087 · Hospital Santa Fe
2007-05 – 2008-01 · Erectile Dysfunction, Hypogonadotrophic Males
What this study did
Early phase / not applicable (3)
Hypogonadism
NCT00119483 · University Hospital of North Norway
2005-09 – 2007-12 · Hypogonadism
What this study did
Other / comorbidity
NCT06188767 · Morten Hostrup, PhD
2025-04-01 – 2028-12-01 · Skeletal Muscle Physiology
What this study did
NCT04134130 · Lund University
2019-09-16 – 2019-12-31 · Prostate Cancer Recurrent
What this study did
Used as active comparator (2)

Other programs' studies in which this drug was the registered active-comparator arm: a marker of standard-of-care status, not evidence of this drug's own progression.

Phase 3 (1)
Hypogonadism
NCT06489457 · University Medical Centre Ljubljana
2020-09-20 – 2023-06-30 · Type 2 Diabetes Mellitus, Obesity, Functional Hypogonadism
What this study did
Phase 1 (1)
Hypogonadism
NCT02966652 · Neurocrine UK Limited
2016-11-03 – 2018-10-04 · Male Hypogonadism
What this study did
Appears in other studies (1)

Studies that reference this drug without giving it an intervention arm of its own: other formulations' programs, background therapy, or registry-search bleed.

Phase 2 (1)
Other / comorbidity
NCT03379012 · Kidney Cancer Research Bureau
2016-02-08 – 2019-07-30 · Metastatic Renal Cell Carcinoma
What this study did

Competitive landscape

No competitors sharing a mechanism or indication in the current universe.

Upcoming events

(6 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow testosterone undecanoate to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2027 (4)
January 2027 (1)
Phase 2HypogonadismRecruiting
Est. primary completion 2027-01-30 · NCT04049331 · CT.gov ↗
What to watch
September 2027 (1)
Phase 2HypogonadismRecruiting
Est. primary completion 2027-09-30 · NCT04798469 · CT.gov ↗
What to watch
December 2027 (2)
Phase 2Multiple Sclerosis, Relapsing-RemittingRecruiting
Est. primary completion 2027-12 · NCT03910738 · CT.gov ↗
What to watch
Early phase / not applicableSkeletal Muscle PhysiologyRecruiting
Est. primary completion 2027-12-01 · NCT06188767 · CT.gov ↗
What to watch
2028 (1)
September 2028 (1)
Phase 4HypogonadismRecruiting
Est. primary completion 2028-09 · NCT03851627 · CT.gov ↗
What to watch
2029 (1)
September 2029 (1)
Phase 2Frail Elderly Patients, Hypogonadal Males, Testosterone Replacement Therapy, Falls (Accidents) in Old AgeNot yet recruiting
Est. primary completion 2029-09-30 · NCT07512323 · CT.gov ↗
What to watch

See the full readout calendar ↗

Regulatory and conference events

(1)

Filings, regulator decisions, scientific presentations, topline results and licensing deals, each from a dated source. When a source gives only the month, the month is shown.

Recent

October 2026ApprovalHealth Canada approves TLANDO
CA, Health Canada · Lipocine Inc. · Source ↗